Results 181 to 190 of about 175,700 (308)

Atypical presentation of macular serpiginous choroiditis masquerading as age related macular degeneration. [PDF]

Am J Ophthalmol Case Rep
Faghihi S, Eshkoly-Lior T, Feo A, Sarraf D.   +3 more
europepmc   +1 more source

Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy

Journal of Diabetes Investigation, EarlyView.
Under physiological conditions, deformable erythrocytes pass smoothly through the capillary network, maintaining retinal capillary perfusion (A). In pathological conditions, reduced erythrocyte deformability causes irregular passage and stagnation within capillaries, resulting in localized blood flow stasis and microvascular congestion, leading to ...
Ye Eun Han, Joon Seo Lim, Yulim Kim, Inhye Kim, Jun Sung Moon, Junyeop Lee   +5 more
wiley   +1 more source

Gene Therapy for Wet Age-Related Macular Degeneration. [PDF]

Bioengineering (Basel)
Barthelemy N, Sridhar J, Sengillo JD.
europepmc   +1 more source

Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial [PDF]

, 2019
Francesco Semeraro, Elena Gambicordi, Anna Cancarini, Francesco Morescalchi, Ciro Costagliola, Andrea Russo   +5 more
openalex   +1 more source

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

Journal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Groeger Sabine Elisabeth, Zhou Yuxi, Yong Jiawen, Wang Lei, Ruf Sabine, Meyle Joerg   +5 more
wiley   +1 more source

Drug Delivery Technologies for the Treatment of Age-Related Macular Degeneration. [PDF]

Adv Sci (Weinh)
Rodriguez-Cruz JJ, Cutrufello J, Lam M, Nallaparaju S, Peppas NA.   +4 more
europepmc   +1 more source

Central versus peripheral macular structure and function: acuity in age-related macular degeneration

, 2020
Ted Maddess, Jo Lane, Emilie Marie Frances Rohan, Rohan W. Essex, Elinor McKone, Faran Sabeti   +5 more
openalex   +1 more source

Nanoengineered photosensitizers for photodynamic priming to overcome P‐glycoprotein‐mediated multidrug resistance

Photochemistry and Photobiology, EarlyView.
Verteporfin's subcellular localization governs its ability to deplete ATP. LysoPC‐conjugated VP accumulates in lysosomes and spares mitochondria, while liposomal and NanoVP formulations target mitochondria, where light activation triggers membrane depolarization and ATP depletion, overcoming resistance seen with free‐form VP. Abstract P‐glycoprotein (P‐
Idrisa Rahman, Anju Meda, Kaitlyn A. Moore, Payal Srivastava, Anika Dasgupta, Andaleeb Sajid, Suresh V. Ambudkar, Huang‐Chiao Huang   +7 more
wiley   +1 more source

Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration. [PDF]

J Nucl Med
Schmidt I, Volkmer P, Müskens RPHM, van der Waaij AM, van Dam GM, Huiskamp EA, Nagengast WB.   +6 more
europepmc   +1 more source

Techniques for subretinal injections in animals

Veterinary Ophthalmology, Volume 28, Issue 2, Page 506-518, March 2025.
Abstract Subretinal injections are not commonly performed during clinical treatment of animals but are frequently used in laboratory animal models to assess therapeutic efficacy and safety of gene and cell therapy products. Veterinary ophthalmologists are often employed to perform the injections in the laboratory animal setting, due to knowledge of ...
Ryan F. Boyd, Simon M. Petersen‐Jones
wiley   +1 more source